1. RODNA
  2. CONICET
  3. CONICET
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.provenanceCONICET-
dc.creatorMarin, Veronica-
dc.creatorGazzin, Silvia-
dc.creatorGambaro, Sabrina Eliana-
dc.creatorDal Ben, Matteo-
dc.creatorCalligaris, Sonia-
dc.creatorAnese, Monica-
dc.creatorRaseni, Alan-
dc.creatorAvellini, Claudio-
dc.creatorGiraudi, Pablo-
dc.creatorTiribelli, Claudio-
dc.creatorRosso, Natalia-
dc.date2018-12-19T13:32:57Z-
dc.date2018-12-19T13:32:57Z-
dc.date2017-09-
dc.date2018-10-22T21:50:43Z-
dc.date.accessioned2019-04-29T15:47:55Z-
dc.date.available2019-04-29T15:47:55Z-
dc.date.issued2017-09-
dc.identifierMarin, Veronica; Gazzin, Silvia; Gambaro, Sabrina Eliana; Dal Ben, Matteo; Calligaris, Sonia; et al.; Effects of oral administration of silymarin in a juvenile murine model of non-alcoholic steatohepatitis; Molecular Diversity Preservation International; Nutrients; 9; 9; 9-2017; 1-21-
dc.identifier2072-6643-
dc.identifierhttp://hdl.handle.net/11336/66725-
dc.identifierCONICET Digital-
dc.identifierCONICET-
dc.identifier.urihttp://rodna.bn.gov.ar:8080/jspui/handle/bnmm/302305-
dc.descriptionThe increasing prevalence of non-alcoholic fatty liver disease (NAFLD) in adolescents is challenging the global care system. No therapeutic strategies have been defined so far, and changes in the lifestyle remain the only alternative. In this study, we assessed the protective effects of silymarin in a juvenile non-alcoholic steatohepatitis (NASH) model and the in vitro effects on fatladen human hepatocytes. C57Bl/6 mice were exposed to HFHC diet immediately after weaning. After eight weeks, animals showed histological signs of NASH. Silymarin was added to the HFHC diet, the treatment continued for additional 12 weeks and the effects on BMI, hepatomegaly, visceral fat, lipid profile, transaminases, HOMA-IR, steatosis, inflammation, fibrosis, oxidative stress, and apoptosis were determined. The switch from HFHC to control diet was used to mimic life style changes. In vitro experiments were performed in parallel in human hepatocytes. HFHC diet supplemented with silymarin showed a significant improvement in glycemia, visceral fat, lipid profile, and liver fibrosis. Moreover, it reduced (both in vitro and in vivo) ALT, hepatic inflammation, oxidative stress, and apoptosis. Lifestyle changes restored the control group parameters. The data presented show the beneficial effects of the oral administration of silymarin in the absence of changes in the dietary habits in a juvenile model of NASH.-
dc.descriptionFil: Marin, Veronica. Centro Studi Fegato; Italia-
dc.descriptionFil: Gazzin, Silvia. Centro Studi Fegato; Italia-
dc.descriptionFil: Gambaro, Sabrina Eliana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Centro Studi Fegato; Italia-
dc.descriptionFil: Dal Ben, Matteo. Centro Studi Fegato; Italia-
dc.descriptionFil: Calligaris, Sonia. Università degli Studi di Trieste; Italia-
dc.descriptionFil: Anese, Monica. Università degli Studi di Trieste; Italia-
dc.descriptionFil: Raseni, Alan. Università degli Studi di Trieste; Italia-
dc.descriptionFil: Avellini, Claudio. Azienda Ospedaliero-Universitaria “Santa Maria della Misericordia”; Italia-
dc.descriptionFil: Giraudi, Pablo. Centro Studi Fegato; Italia-
dc.descriptionFil: Tiribelli, Claudio. Centro Studi Fegato; Italia-
dc.descriptionFil: Rosso, Natalia. Centro Studi Fegato; Italia-
dc.formatapplication/pdf-
dc.formatapplication/pdf-
dc.languageeng-
dc.publisherMolecular Diversity Preservation International-
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/https://dx.doi.org/10.3390/nu9091006-
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.mdpi.com/2072-6643/9/9/1006-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/-
dc.sourcereponame:CONICET Digital (CONICET)-
dc.sourceinstname:Consejo Nacional de Investigaciones Científicas y Técnicas-
dc.sourceinstacron:CONICET-
dc.source.urihttp://hdl.handle.net/11336/66725-
dc.subjectFIBROSIS-
dc.subjectIN VITRO MODEL-
dc.subjectIN VIVO MODEL-
dc.subjectNAFLD-
dc.subjectNASH-
dc.subjectSILYMARIN-
dc.subjectTHERAPEUTIC APPROACH-
dc.subjectSalud Ocupacional-
dc.subjectCiencias de la Salud-
dc.subjectCIENCIAS MÉDICAS Y DE LA SALUD-
dc.titleEffects of oral administration of silymarin in a juvenile murine model of non-alcoholic steatohepatitis-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.typeinfo:ar-repo/semantics/articulo-
Aparece en las colecciones: CONICET

Ficheros en este ítem:
No hay ficheros asociados a este ítem.
Mostrar el registro sencillo del ítem